MiR-7-5p-mediated downregulation of PARP1 impacts DNA homologous recombination repair and resistance to doxorubicin in small cell lung cancer

被引:0
|
作者
Jinzhi Lai
Hainan Yang
Yanyang Zhu
Mei Ruan
Yayu Huang
Qiuyu Zhang
机构
[1] Fujian Medical University,Department of Oncology, The Second Affiliated Hospital
[2] Fujian Medical University,Institute of Immunotherapy
[3] The Second Affiliated Hospital,Department of Ultrasound
[4] Fujian Medical University,undefined
来源
BMC Cancer | / 19卷
关键词
Small cell lung cancer; MiR-7-5p; Chemo-resistance; Doxorubicin; Poly ADP-ribose polymerase 1; Homologous recombination;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer
    Kim, Ho-Cheol
    Song, Joon Seon
    Lee, Jae Cheol
    Lee, Dae Ho
    Kim, Sang-We
    Lee, Jung-Shin
    Kim, Woo Sung
    Rho, Jin Kyung
    Kim, Sun Ye
    Choi, Chang-Min
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (10): : 6743 - 6751
  • [32] Analysis of homologous recombination DNA repair gene mutation status in patients with metastatic small cell lung cancer treated with cediranib and olaparib on NCI 9881 study.
    Kim, Joseph W.
    Radke, Marc R.
    Hafez, Navid
    Soliman, Hatem Hussein
    Fu, Siqing
    Kato, Shumei
    Lara, Primo
    Vaishampayan, Ulka N.
    Razak, Albiruni Ryan Abdul
    Cardin, Dana Backlund
    Munster, Pamela N.
    Eder, Joseph Paul
    Shyr, Yu
    Ivy, S. Percy
    LoRusso, Patricia
    Swisher, Elizabeth M.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [33] LINC02389/miR-7-5p Regulated Cisplatin Resistance of Non-Small-Cell Lung Cancer via Promoting Oxidative Stress
    Ma, Peng
    Han, Wen
    Meng, Cunying
    Tan, Xiaohong
    Liu, Pengfei
    Dong, Lei
    ANALYTICAL CELLULAR PATHOLOGY, 2022, 2022
  • [34] GLIDR-mediated regulation of tumor malignancy and cisplatin resistance in non-small cell lung cancer via the miR-342-5p/PPARGC1A axis
    Liu, Ruihua
    Wang, Jiemin
    Zhang, Lichun
    Wang, Shu
    Li, Xiangnan
    Liu, Yueshi
    Yu, Haiquan
    BMC CANCER, 2024, 24 (01)
  • [35] The relationship between miR-17-5p, miR-92a, and let-7b expression with non-small cell lung cancer targeted drug resistance
    Gong, Jianhua
    He, Li
    Ma, Jingping
    Zhang, Jiahong
    Wang, Lixin
    Wang, Jipeng
    JOURNAL OF BUON, 2017, 22 (02): : 454 - 461
  • [36] Role of MiR-3619-5p in β-Catenin-Mediated Non-Small Cell Lung Cancer Growth and Invasion
    Niu, Xuecai
    Liu, Sen
    Jia, Li
    Chen, Jing
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2015, 37 (04) : 1527 - 1536
  • [37] Correction to: Dexmedetomidine suppresses bupivacaine-induced parthanatos in human SH-SY5Y cells via the miR-7-5p/PARP1 axis-mediated ROS
    Ting Zheng
    Chunying Zheng
    Fei Gao
    Fengyi Huang
    Bin Hu
    Xiaochun Zheng
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2021, 394 : 1055 - 1056
  • [38] miR-145-5p Modulates Gefitinib Resistance by Targeting NRAS and MEST in Non-Small Cell Lung Cancer
    Yu, Chuigong
    Li, Bingqing
    Wang, Jinghao
    Zhang, Ziyue
    Li, Shengjing
    Lei, Shixiong
    Wang, Qinhao
    ANNALS OF CLINICAL AND LABORATORY SCIENCE, 2021, 51 (05): : 625 - 637
  • [39] Downregulation of hsa_circTLK1 represses non-small cell lung cancer progression by regulating miR-876-3p/SRSF7 axis
    Dong, Xinzhe
    Tian, Hui
    Ren, Peng
    Liu, Yanxia
    Wang, Lin
    HELIYON, 2024, 10 (11)
  • [40] The regulation of autophagy by the miR-199a-5p/p62 axis was a potential mechanism of small cell lung cancer cisplatin resistance
    Li, Tiezhi
    Zhang, Helin
    Wang, Zhichao
    Gao, Shaolin
    Zhang, Xu
    Zhu, Haiyong
    Wang, Na
    Li, Honglin
    CANCER CELL INTERNATIONAL, 2022, 22 (01)